Rhabdoid Carcinoma Innovations
Rhabdoid
tumor may be a rare, aggressive, and highly fatal disease that typically presents within the kidneys of youngsters . Extrarenal rhabdoid
tumor has been identified in various tissue types throughout the body, most ordinarily within the brain, but despite its wide phenotypic diversity nearly all rhabdoid
tumors share an equivalent genotypic origin. We present a case of rhabdoid
tumor of the plexus brachialis , the second such case to be reported, and a quick review of the literature. Our patient may be a five-year-old female who presented with sensorimotor symptoms of her arm. Her initial imaging suggested a possible malignant peripheral nerve sheath tumor. She underwent surgical decompression via an infraclavicular approach; complete resection wasn't possible. The
pathology was according to extrarenal rhabdoid tumor. She is being treated with alternating cycles of
chemotherapy consisting of ICE and VDC.Rhabdoid
tumor (RT) was first described as a rare variant of Wilms tumor,
accounting for fewer than 2% of childhood renal
tumors [1]. The median age of diagnosis is 11–18 months [2], [3]. It typically presents as high-stage disease, and progresses rapidly with most deaths occurring within 12 months of presentation [4]. RT also occurs outside of the kidney, most ordinarily within the
brain but throughout the remainder of the body also , where it's even rarer and deadlier.
High Impact List of Articles
-
Rhabdomyomatosis of the
heart associated with tuberous
sclerosis. A case report and
review of the literature
Kouroupi Maria, Alexiadis Triantafyllos, Karamanidis Dimitrios, Koutsougeras Gerasimos, Giatromanolaki Alexandra and Lambropoulou Maria
Case Report: Clinical Practice
-
Rhabdomyomatosis of the
heart associated with tuberous
sclerosis. A case report and
review of the literature
Kouroupi Maria, Alexiadis Triantafyllos, Karamanidis Dimitrios, Koutsougeras Gerasimos, Giatromanolaki Alexandra and Lambropoulou Maria
Case Report: Clinical Practice
-
Fenofibrate effects on cardiovascular outcomes in patients with diabetes and metabolic syndrome
Brian K Irons
Research Highlights: Clinical Practice
-
Fenofibrate effects on cardiovascular outcomes in patients with diabetes and metabolic syndrome
Brian K Irons
Research Highlights: Clinical Practice
-
Vildagliptin: novel pharmacological approach to treat Type 2 diabetes
Bo Ahraain
Drug Evaluation: Clinical Practice
-
Vildagliptin: novel pharmacological approach to treat Type 2 diabetes
Bo Ahraain
Drug Evaluation: Clinical Practice
-
Controversies in vitamin D: deficiency and supplementation after Roux-en-Y gastric bypass surgery
Kerstyn C Zalesin, Wendy M Miller, Katherine E Nori Janosz, Jose Yanez, Kevin Krause, David L Chengelis and Peter A McCullough
Review Article: Clinical Practice
-
Controversies in vitamin D: deficiency and supplementation after Roux-en-Y gastric bypass surgery
Kerstyn C Zalesin, Wendy M Miller, Katherine E Nori Janosz, Jose Yanez, Kevin Krause, David L Chengelis and Peter A McCullough
Review Article: Clinical Practice
-
Ondansetron for postoperative nausea and vomiting
Ira Todd Cohen
Drug Evaluation: Clinical Practice
-
Ondansetron for postoperative nausea and vomiting
Ira Todd Cohen
Drug Evaluation: Clinical Practice
Relevant Topics in Clinical